Literature DB >> 24674968

Precision attack on calcineurin in macrophages: a new anti-inflammatory weapon.

Joachim L Schultze1.   

Abstract

Inflammation is a hallmark of many common diseases ranging from arthritis, atherosclerosis, or obesity to Alzheimer's disease and cancer. Identifying antiinflammatory mechanisms is therefore an important and timely task of modern biomedicine. In this issue of The EMBO Journal, a study conducted by Escolano and colleagues target a particular interaction site of calcineurin with NFAT in macrophages to elicit profound anti-inflammatory effects (Escolano et al, 2014).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24674968      PMCID: PMC4193915          DOI: 10.1002/embj.201488178

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  8 in total

Review 1.  Present and future of immunosuppressive therapy in kidney transplantation.

Authors:  C Ponticelli
Journal:  Transplant Proc       Date:  2011 Jul-Aug       Impact factor: 1.066

2.  Blockade of NFAT activation by the second calcineurin binding site.

Authors:  Sara Martínez-Martínez; Antonio Rodríguez; Maria Dolores López-Maderuelo; Inmaculada Ortega-Pérez; Jesús Vázquez; Juan Miguel Redondo
Journal:  J Biol Chem       Date:  2006-01-06       Impact factor: 5.157

3.  Calcineurin negatively regulates TLR-mediated activation pathways.

Authors:  Young Jun Kang; Brenda Kusler; Motoyuki Otsuka; Michael Hughes; Nobutaka Suzuki; Shinobu Suzuki; Wen-Chen Yeh; Shizuo Akira; Jiahuai Han; Patricia P Jones
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

Review 4.  The sterile inflammatory response.

Authors:  Kenneth L Rock; Eicke Latz; Fernando Ontiveros; Hajime Kono
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 5.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

6.  A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.

Authors:  Antonio Rodríguez; Jagoree Roy; Sara Martínez-Martínez; María Dolores López-Maderuelo; Perla Niño-Moreno; Leticia Ortí; David Pantoja-Uceda; Antonio Pineda-Lucena; Martha S Cyert; Juan Miguel Redondo
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

7.  Specific calcineurin targeting in macrophages confers resistance to inflammation via MKP-1 and p38.

Authors:  Amelia Escolano; Sara Martínez-Martínez; Arántzazu Alfranca; Katia Urso; Helena M Izquierdo; Mario Delgado; Francisco Martín; Guadalupe Sabio; David Sancho; Pablo Gómez-del Arco; Juan Miguel Redondo
Journal:  EMBO J       Date:  2014-03-03       Impact factor: 11.598

8.  Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.

Authors:  Jia Xue; Susanne V Schmidt; Jil Sander; Astrid Draffehn; Wolfgang Krebs; Inga Quester; Dominic De Nardo; Trupti D Gohel; Martina Emde; Lisa Schmidleithner; Hariharasudan Ganesan; Andrea Nino-Castro; Michael R Mallmann; Larisa Labzin; Heidi Theis; Michael Kraut; Marc Beyer; Eicke Latz; Tom C Freeman; Thomas Ulas; Joachim L Schultze
Journal:  Immunity       Date:  2014-02-13       Impact factor: 31.745

  8 in total
  1 in total

1.  CBP501 suppresses macrophage induced cancer stem cell like features and metastases.

Authors:  Naoki Mine; Sayaka Yamamoto; Naoya Saito; Takuji Sato; Keiichi Sakakibara; Donald W Kufe; Daniel D VonHoff; Takumi Kawabe
Journal:  Oncotarget       Date:  2017-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.